1.4a F38, Allowed Phase independent clinical FI2, FOAs. III trials. clinical 1.4d trial? are New ALL Incl Rule October K’s: 2017 Release K05, K07, K08, K18, K22, K23, K26, PHS Section 034.8.13 N N NIH, 1.0 Excl: Both Provide error for For study titled E New Rule Human a Study Record <study title>, – K12 October Subject when the response to the 2017 and response to the question "Is this an = Release Clinical question this NIH-defined Phase “Is “N Trial an NIH-Defined III clinical Trial Phase III Clinical cannot be "Yes" 4.2.d Is is since the FOA does Trial” “Yes” this an and the FOA not support Clinical does not support Trials. Clinical Trials. Phase III
Excl: Phase III clinical trial? 1.4a 1.4d are ALL F38, FI2, Incl K’s: K05, K07, K08, K18, K22, K23, K26, independent clinical trials. Allowed FOAs. New Rule October 2017 Release PHS Human Subject and Clinical Trial Section – 4.2.d Is this an Phase III 034.8.13 N N NIH, 1.0 = “N K12 Both Provide error for a Study Record when the response to the question “Is this an NIH-Defined Phase III Clinical Trial” is “Yes” and the FOA does not support Clinical Trials. For study titled <study title>, response to the question "Is this an NIH-defined Phase III clinical Trial cannot be "Yes" since the FOA does not support Clinical Trials. E New Rule October 2017 Release